Clinical Laboratory News

Featured Clinical Laboratory News

Mario Motta, MD, joins COLA Inc. Board of Directors

COLA Inc., a national laboratory accreditor dedicated to quality in laboratory medicine and patient care, announces the appointment of Mario Motta, MD, to its Board of Directors. Dr. Motta is a board-certified cardiologist from Salem, Massachusetts, and he joins COLA Inc.’s board of prominent professionals appointed by AAFP, ACP, and AMA. In addition to being…

Details

COLA Inc. Conducting New Survey on PAMA’s Impact on Clinical Laboratories

COLA Inc., a nationally-recognized private, non-profit laboratory accreditation organization, is inviting clinical laboratories to participate in a new survey to gather data about how cuts in Medicare’s Clinical Laboratory Fee Schedule (CLFS) are impacting their services to patients. Since the implementation of the Protecting Access to Medicare Act (PAMA) of 2014, clinical laboratories have experienced…

Details

Recent Articles

ZIKA Virus and ZIKA Virus Infection

Instant Access Webinar Presented by John Daly, Chief Medical Officer, COLA Description: Over the past year, Zika virus and virus infection have been in the news on a regular basis. This presentation gives a very brief overview of Zika and provides information on clinical and laboratory resources that are kept updated and can be utilized…

Credit: Architect of the Capitol

What Does the Debt Ceiling Deal Mean for Labs?

The American Clinical Laboratory Association, of which COLA is an associate member, prepared this analysis of the impact the debt ceiling compromise agreed to by President Obama and Congress will have on the lab industry. The Debt Ceiling Compromise and What It Means for Labs The legislation, once enacted, sets up essentially two stages to…

The Impact of the PAMA Regulations on POLs – PART 2

Instant Access Webinar Hosted by John Daly, M.D., Chief Medical Officer, COLA Description: Dr. Daly presents a comprehensive background of the Protecting Access to Medicare Act (PAMA.) CMS has recently released the HCPCS codes that must be reported under the PAMA regulations. This brief update discusses reportable analytes and location of the applicable test codes.…

The Impact of PAMA Regulations on POLS – Part 4

Instant Access Webinar Hosted by John Daly, M.D., Chief Medical Officer, COLA Description: Dr. Daly presents a comprehensive background of the Protecting Access to Medicare Act (PAMA.) This update covers the CMS update of the Frequent Asked Questions about the PAMA regulations. The update aims to provide further clarification as to which physician office-based labs will be…

The Impact of PAMA Regulations on POLS – Part 3

Instant Access Webinar Hosted by John Daly, M.D., Chief Medical Officer, COLA Description: Dr. Daly presents a comprehensive background of the Protecting Access to Medicare Act (PAMA.) This PAMA update informs of the CMS newly released laboratory test reporting format. Learn More from CMS by Clicking Here Cost: FREE Click Here to View The Impact of…

The Impact of PAMA Regulations on POLs

In 2014, Congress passed PAMA Regulations (Protecting Access to Medicare Act) to direct the Centers for Medicare and Medicaid Services (CMS) to develop a market-based methodology for determining the future rates Medicare will pay for tests under the Clinical Laboratory Fee Schedule. Analysis shows that the current data collection and evaluative pricing methodology, if fully…